BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1377291)

  • 1. [Anti-platelet antibody and platelet function].
    Kurata Y; Tomiyama Y
    Nihon Rinsho; 1992 Feb; 50(2):287-91. PubMed ID: 1377291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the binding of an alloimmune and two murine monoclonal antibodies to the platelet glycoprotein IIb-IIIa complex receptor.
    Coller BS; Peerschke EI; Seligsohn U; Scudder LE; Nurden AT; Rosa JP
    J Lab Clin Med; 1986 Apr; 107(4):384-92. PubMed ID: 2420911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A human monoclonal autoantibody specific for human platelet glycoprotein IIb (integrin alpha IIb) heavy chain.
    Kunicki TJ; Furihata K; Kekomaki R; Scott JP; Nugent DJ
    Hum Antibodies Hybridomas; 1990; 1(2):83-95. PubMed ID: 1715776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa].
    Khaspekova SG; Vyzova TV; Lukin VV; Tikhomirov OIu; Berndt M; Kouns W; Mazurov AV
    Biokhimiia; 1996 Mar; 61(3):412-28. PubMed ID: 8724599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences between platelet and microparticle glycoprotein IIb/IIIa.
    Nomura S; Suzuki M; Kido H; Yamaguchi K; Fukuroi T; Yanabu M; Soga T; Nagata H; Kokawa T; Yasunaga K
    Cytometry; 1992; 13(6):621-9. PubMed ID: 1451594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A monoclonal antibody to the human platelet glycoprotein IIb/IIIa complex induces platelet activation.
    Modderman PW; Huisman HG; van Mourik JA; von dem Borne AE
    Thromb Haemost; 1988 Aug; 60(1):68-74. PubMed ID: 2973154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exposure of platelet fibrinogen receptors by a monoclonal antibody to the GPIIb-IIIa complex, PMA4.
    Watanabe A; Hato T; Kobayashi Y
    Int J Hematol; 1992 Aug; 56(1):79-87. PubMed ID: 1382664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asialo von Willebrand factor interactions with platelets. Interdependence of glycoproteins Ib and IIb/IIIa for binding and aggregation.
    Grainick HR; Williams SB; Coller BS
    J Clin Invest; 1985 Jan; 75(1):19-25. PubMed ID: 2981249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of human platelet IgG Fc receptor associated with membrane glycoprotein.
    Shido K; Ahmad G; Hsu L; Kamiyama M
    J Clin Lab Immunol; 1995; 46(1):1-11. PubMed ID: 9363587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Arg-Gly-Asp (RGD) recognition site of platelet glycoprotein IIb-IIIa on nonactivated platelets is accessible to high-affinity macromolecules.
    Tomiyama Y; Tsubakio T; Piotrowicz RS; Kurata Y; Loftus JC; Kunicki TJ
    Blood; 1992 May; 79(9):2303-12. PubMed ID: 1373972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A variant of Glanzmann's thrombasthenia with abnormal glycoprotein IIb-IIIa complexes in the platelet membrane.
    Nurden AT; Rosa JP; Fournier D; Legrand C; Didry D; Parquet A; Pidard D
    J Clin Invest; 1987 Mar; 79(3):962-9. PubMed ID: 3818957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired disorder of platelet function associated with autoantibodies against membrane glycoprotein IIb-IIIa complex--1. Glycoprotein analysis.
    Meyer M; Kirchmaier CM; Schirmer A; Spangenberg P; Ströhl C; Breddin K
    Thromb Haemost; 1991 May; 65(5):491-6. PubMed ID: 1871709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Divalent cation regulation of the surface orientation of platelet membrane glycoprotein IIb. Correlation with fibrinogen binding function and definition of a novel variant of Glanzmann's thrombasthenia.
    Ginsberg MH; Lightsey A; Kunicki TJ; Kaufmann A; Marguerie G; Plow EF
    J Clin Invest; 1986 Oct; 78(4):1103-11. PubMed ID: 2428841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial inhibition of platelet aggregation and fibrinogen binding by a murine monoclonal antibody to GPIIIa: requirement for antibody bivalency.
    Kutok JL; Coller BS
    Thromb Haemost; 1994 Dec; 72(6):964-72. PubMed ID: 7537915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a monoclonal antibody to glycoprotein IIb/IIIa (P256) and of enzymically derived fragments of P256 on human platelets.
    Stuttle AW; Powling MJ; Ritter JM; Hardisty RM
    Thromb Haemost; 1991 Apr; 65(4):432-7. PubMed ID: 2057927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of alternative mechanisms of collagen-induced platelet activation by using monoclonal antibodies to glycoprotein IIb-IIIa and fibrinogen.
    Connellan JM; Thurlow PJ; Barlow B; Lowe M; McKenzie IF
    Thromb Haemost; 1986 Apr; 55(2):153-7. PubMed ID: 2940722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of platelet aggregation disorders based on flow cytometric analysis of membrane glycoprotein IIb-IIIa with conformation-specific monoclonal antibodies.
    Ginsberg MH; Frelinger AL; Lam SC; Forsyth J; McMillan R; Plow EF; Shattil SJ
    Blood; 1990 Nov; 76(10):2017-23. PubMed ID: 2242424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The fibrinogen gamma chain dodecapeptide inhibits agonist-induced aggregation of rabbit platelets and fibrinogen binding to rabbit glycoprotein IIb-IIIa.
    Rand ML; Packham MA; Taylor DM; Yeo EL; Gemmell CH; Patil S; Lam SC
    Thromb Haemost; 1999 Dec; 82(6):1680-6. PubMed ID: 10613655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of an antibody to the integrin beta 3 subunit (GP IIIa) from a patient with neonatal thrombocytopenia and an inherited deficiency of GP IIb-IIIa complexes in platelets (Glanzmann's thrombasthenia).
    Jallu V; Pico M; Chevaleyre J; Vézon G; Kunicki TJ; Nurden AT
    Hum Antibodies Hybridomas; 1992 Apr; 3(2):93-106. PubMed ID: 1633270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of platelet membrane glycoproteins Ib/IX and IIb/IIIa, and of platelet alpha-granule proteins in platelet aggregation induced by human osteosarcoma cells.
    Clezardin P; Drouin J; Morel-Kopp MC; Hanss M; Kehrel B; Serre CM; Kaplan C; Delmas PD
    Cancer Res; 1993 Oct; 53(19):4695-700. PubMed ID: 7691402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.